Eli Lilly Sells Two Legacy Drugs and Manufacturing Facility for $375M
Eddingpharm forked over $375 million for the rights to sell Ceclor and Vancocin in China, as well as a manufacturing facility that makes the two medications.
The Home of the Life Sciences Industry
Explore Latest News
Planned Emeryville Life Sciences Development Challenged by Competing Developer
The rival developer appealed the recently approved 150,000 square foot development, saying it would shrink the amount of space between buildings.
- Anit-Vaxxer Movement Cites Distrust of Pharma Industry as Big Reason to Skip Shots
- IQVIA Report: Biopharma R&D Investment Has Increased 32% Over Last 5 Years
- UK-Based Accelerator Start Codon Launches with Investment from Genentech and Others
- Google Steps Up Efforts to Use Artificial Intelligence in Health Care
- Are You the Leadership Problem? How to Improve Your Leadership Skills to Get the Results You Want
Get personalized job alerts
Create a job alert and receive custom job recommendations straight to your inbox.
Employers
Post jobs on BioSpace and start building your talent pipeline today. Click the button to access our easy eCommerce site, which lets you purchase and post jobs in just a few clicks.